TITLE

Erratum to: Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes

AUTHOR(S)
Ortega, Francisco; Mercader, Josep; Moreno-Navarrete, José; Sabater, Mónica; Pueyo, Neus; Valdés, Sergio; Ruiz, Bartomeu; Luche, Elodie; Serino, Matteo; Naon, Deborah; Ricart, Wifredo; Botas, Patricia; Delgado, Elias; Burcelin, Remy; Frühbeck, Gema; Bosch, Fatima; Mingrone, Gertrude; Zorzano, Antonio; Fernández-Real, José
PUB. DATE
April 2013
SOURCE
Journal of Molecular Medicine;Apr2013, Vol. 91 Issue 4, p535
SOURCE TYPE
Academic Journal
DOC. TYPE
Correction notice
ABSTRACT
A correction to the article "Targeting the Association of Calgranulin B (S100A9) With Insulin Resistance and Type 2 Diabetes" that was published in the March 8, 2013 issue is presented.
ACCESSION #
86419195

 

Related Articles

  • Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction. Lebovitz, Harold E.; Kreider, Margaret; Freed, Martin I. // Diabetes Care;May2002, Vol. 25 Issue 5, p815 

    Objective: Troglitazone treatment has been associated with idiosyncratic hepatic reaction leading to hepatic failure and death in some patients. This raises questions regarding whether all thiazolidinediones or peroxisomal proliferator-activated receptor-gamma (PPAR-gamma) agonists...

  • The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients. Poulsen, Mikael KÆr; Henriksen, Jan Erik; Hother-Nielsen, Ole; Beck-Nielsen, Henning; Poulsen, Mikael Kjaer // Diabetes Care;Dec2003, Vol. 26 Issue 12, p3273 

    Objective: Type 2 diabetes is caused by reduced insulin secretion and insulin resistance in skeletal muscle and liver. We tested the combination therapy with insulin aspart, rosiglitazone, and metformin with the purpose of treating all three defects in order to test the hypothesis...

  • Treating Type 2 Diabetes Mellitus: A Growing Epidemic. Weinstock, Ruth S. // Mayo Clinic Proceedings;Apr2003, Vol. 78 Issue 4, p411 

    Editorial. Introduces articles published in the April 2003 issue of 'Mayo Clinic Proceedings' journal. Treatment of type-2 diabetes mellitus. Prevalence; Importance of early diagnosis for the initiation of aggressive treatment to prevent complications; Glycemic control; Insulin resistance.

  • Homeostasis Model Assessment as a Clinical Index of Insulin Resistance in Type 2 Diabetic Patients Treated With Sulfonylureas. Emoto, Masanori; Nishizawa, Yoshiki; Maekawa, Kiyoshi; Hiura, Yoshikazu; Kanda, Hiroyuki; Kawagishi, Takahiko; Shoji, Tetsuo; Okuno, Yasuhisa; Morii, Hirotoshi // Diabetes Care;May99, Vol. 22 Issue 5, p818 

    Presents information on a study which investigated whether homeostasis model assessment is associated with the insulin euglycemic-hyperinsulinemic clamp in a restrospective analysis in type two diabetic patients treated with sulfonylureas. Research design and methods; Results; Conclusions.

  • In This Issue of . Bingham, Max // Diabetes;Jul2017, Vol. 66 Issue 7, p1733 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the use of growth differentiation factor 11 (GDF11) in treating type 2 diabetes, the link of miR-29 in skeletal muscle to insulin sensitivity in type 2 diabetes, and the ability of...

  • Cinnamon: New Applications for An Old Spice. Hawkins, Ernest B. // Natural Pharmacy;Aug2004, Vol. 8 Issue 4, p12 

    Discusses the potential of cinnamon to help the response to insulin in type 2 diabetes. Role of cinnamon in Traditional Chinese Medicine; Regulation of blood sugar levels; Use of cinnamon oil to treat oral candidiasis in patients with acquired immune deficiency syndrome.

  • 7. Physical activity and type 2 diabetes mellitus.  // Journal of Endocrinology, Metabolism & Diabetes of South Africa;Jun2012, Vol. 17 Issue 2, pS18 

    The article discusses the importance of physical activity in the management of type 2 diabetes. It states that regular physical activity provides several benefits to diabetic patients including increased cardiorespiratory fitness, decreased insulin resistance and improved glycaemic control....

  • CLINICAL ROUNDS: Medications in Diabetes Management. Wilchowski, Sara; Waack, Stacy; Levine, Shel // Clinical Kinesiology (Online Edition);Winter2007, p25 

    No abstract available.

  • Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit. Papaetis, Georgios S.; Orphanidou, Dora; Panagiotou, Themistoklis N. // Current Drug Targets;Sep2011, Vol. 12 Issue 10, p1498 

    No abstract available.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics